Federated Hermes’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Federated Hermes's VRTX Position: Q2 2026 in Review
Federated Hermes reduced its Vertex Pharmaceuticals (VRTX) stake by 41% in Q2 2026, selling an estimated $12.9M and leaving 42,663 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #484.
Federated Hermes first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $106M in Q2 2020. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Federated Hermes held 42,663 shares of Vertex Pharmaceuticals worth $21.2M as of Q2 2026.
- Federated Hermes sold 29,159 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.9M.
- Vertex Pharmaceuticals made up 0.03% of Federated Hermes's portfolio in Q2 2026, its #484 holding.
- Federated Hermes first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Vertex Pharmaceuticals position peaked at $106M in Q2 2020.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.